95-20564. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products; Correction  

  • [Federal Register Volume 60, Number 160 (Friday, August 18, 1995)]
    [Proposed Rules]
    [Page 43091]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-20564]
    
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Parts 310 and 341
    
    [Docket No. 94N-0247]
    RIN 0905-AA06
    
    
    Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug 
    Products for Over-the-Counter Human Use; Proposed Amendment of 
    Monograph for OTC Bronchodilator Drug Products; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice of proposed rulemaking; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a 
    proposal that appeared in the Federal Register of March 9, 1995 (60 FR 
    13014). That document proposed to amend the final monograph for over-
    the-counter (OTC) bronchodilator drug products to remove pressurized 
    metered-dose aerosol container dosage forms for the ingredients 
    epinephrine, epinephrine bitartrate, and racepinephrine hydrochloride. 
    The document was published with two errors. This document corrects 
    those errors.
    
    FOR FURTHER INFORMATION CONTACT: LaJuana D. Caldwell, Office of Policy 
    (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 
    20857, 301-443-2994.
    
    SUPPLEMENTARY INFORMATION: In FR Doc. 95-5825, appearing on page 13014 
    in the Federal Register of March 8, 1995, the following corrections are 
    made:
    
    
    Sec. 310.545  [Corrected]
    
        1. On page 13020, in the third column, in Sec. 310.545 Drug 
    products containing certain active ingredients offered over-the-counter 
    (OTC) for certain uses, in paragraph (a)(6)(iv)(C), the words ``April 
    10, 1995'' are corrected to read ``(date 30 days after date of 
    publication of the final rule)''; and in paragraph (d)(26), the words 
    ``April 10, 1995'' are corrected to read ``(Date 30 days after date of 
    publication of the final rule)''.
    
        Dated: August 14, 1995.
    William K. Hubbard,
    Acting Deputy Commissioner for Policy.
    [FR Doc. 95-20564 Filed 8-17-95; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Published:
08/18/1995
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notice of proposed rulemaking; correction.
Document Number:
95-20564
Pages:
43091-43091 (1 pages)
Docket Numbers:
Docket No. 94N-0247
RINs:
0905-AA06
PDF File:
95-20564.pdf